Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
Rhea-AI Summary
Clover Health (Nasdaq: CLOV) announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025 at 11:00 a.m. Eastern Time.
A live webcast and replay will be available on Clover Health's investor relations website at https://investors.cloverhealth.com/.
Positive
- None.
Negative
- None.
News Market Reaction 2 Alerts
On the day this news was published, CLOV declined 4.35%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $70M from the company's valuation, bringing the market cap to $1.54B at that time.
Data tracked by StockTitan Argus on the day of publication.
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time.
A live webcast and replay of the presentation will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
When will Clover Health (CLOV) present at the 2025 UBS Global Healthcare Conference?
Who from Clover Health (CLOV) is presenting at the UBS Global Healthcare Conference?
Where can I watch Clover Health's (CLOV) UBS conference presentation live?
Will there be a replay of Clover Health's (CLOV) UBS Global Healthcare presentation?
Is Clover Health (CLOV) providing investor materials or a slide deck for the UBS presentation?
How can investors get reminders or access to Clover Health's (CLOV) November 11, 2025 webcast?
